Notify me when Sphera Funds Management Ltd. files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 101 | $422M | +$109M | -$168M | -$59.4M | TEVA, NICE, TSEM, NVMI, QQQ | 13F-HR | 11/14/2025, 03:30 PM |
| Q2 2025 | 101 | $382M | +$79.8M | -$120M | -$40.1M | TEVA, NVMI, SNDX, TSEM, CYTK | 13F-HR | 8/14/2025, 03:33 PM |
| Q1 2025 | 112 | $405M | +$62.2M | -$121M | -$58.7M | TEVA, SNDX, SNY, NVMI, AZN | 13F-HR | 5/15/2025, 03:31 PM |
| Q4 2024 | 103 | $541M | +$102M | -$125M | -$23M | TEVA, BBIO, SNY, SNDX, AZN | 13F-HR | 2/14/2025, 02:33 PM |
| Q3 2024 | 108 | $610M | +$137M | -$136M | +$886K | TEVA, SNY, BBIO, SNDX, AMZN | 13F-HR | 11/14/2024, 03:15 PM |
| Q2 2024 | 110 | $610M | +$168M | -$126M | +$42.6M | BBIO, SNY, CYTK, AMZN, SNDX | 13F-HR | 8/14/2024, 03:36 PM |
| Q1 2024 | 91 | $615M | +$179M | -$175M | +$4.35M | TEVA, SNY, NICE, CYTK, SNDX | 13F-HR | 5/15/2024, 03:42 PM |
| Q4 2023 | 88 | $533M | +$155M | -$214M | -$58.3M | TEVA, SNY, CYTK, NVMI, SNDX | Restatement | 2/15/2024, 07:40 AM |
| Q3 2023 | 106 | $549M | +$159M | -$227M | -$68.1M | TEVA, SNY, AZN, NICE, JNJ | 13F-HR | 11/14/2023, 03:54 PM |
| Q2 2023 | 108 | $640M | +$259M | -$237M | +$21.6M | TEVA, QQQ, SNY, AZN, JNJ | 13F-HR | 8/14/2023, 04:45 PM |
| Q1 2023 | 81 | $598M | +$377M | -$33.5M | +$344M | IWM, SPY, SNY, NICE, AZN | 13F-HR | 5/15/2023, 04:14 PM |
| Q4 2022 | 63 | $466M | +$123M | -$287M | -$164M | AZN, SNY, JNJ, SNDX, MRK | 13F-HR | 2/14/2023, 02:36 PM |
| Q3 2022 | 71 | $712M | +$356M | -$76.1M | +$280M | AZN, LLY, SNY, JNJ, MRK | 13F-HR | 11/14/2022, 03:20 PM |
| Q2 2022 | 54 | $926M | +$530M | -$38.9M | +$491M | QQQ, SPY, AZN, JNJ, LLY | 13F-HR | 8/15/2022, 03:32 PM |
| Q1 2022 | 66 | $703M | +$235M | -$135M | +$99.9M | AZN, JNJ, SNY, QQQ, ABBV | 13F-HR | 5/16/2022, 03:34 PM |
| Q4 2021 | 89 | $879M | +$255M | -$214M | +$41.5M | ABBV, AZN, SNY, LLY, MRK | 13F-HR | 2/14/2022, 02:24 PM |
| Q3 2021 | 107 | $1.01B | +$351M | -$350M | +$235K | LLY, AZN, ABBV, PFE, SNY | 13F-HR | 11/15/2021, 03:41 PM |
| Q2 2021 | 120 | $1.05B | +$259M | -$356M | -$97.1M | AZN, JNJ, MRK, SNY, GNRC | 13F-HR | 8/16/2021, 06:15 PM |
| Q1 2021 | 158 | $1.09B | +$463M | -$305M | +$158M | LLY, JNJ, ABBV, MRK, SNY | 13F-HR | 5/17/2021, 06:01 AM |
| Q4 2020 | 109 | $1.13B | +$499M | -$232M | +$267M | LLY, SRPT, MRK, JNJ, XBI | 13F-HR | 2/16/2021, 05:29 AM |
| Q3 2020 | 91 | $993M | +$346M | -$108M | +$238M | MRK, ABBV, QQQ, JNJ, SNY | 13F-HR | 11/12/2020, 05:59 AM |
| Q2 2020 | 87 | $1.06B | +$453M | -$101M | +$352M | XBI, ABBV, MRK, SPY, SNY | 13F-HR | 8/13/2020, 06:02 AM |
| Q1 2020 | 77 | $795M | +$353M | -$265M | +$87.9M | IWM, MRK, SPY, JNJ, BMY | 13F-HR | 5/14/2020, 07:49 AM |
| Q4 2019 | 86 | $1.21B | +$678M | -$126M | +$552M | XBI, IBB, JNJ, BMY, SNY | 13F-HR | 2/13/2020, 11:11 AM |
| Q3 2019 | 79 | $647M | +$242M | -$54.4M | +$188M | BMY, JNJ, GILD, MRK, SNY | 13F-HR | 11/14/2019, 05:01 AM |
| Q2 2019 | 89 | $731M | +$235M | -$42.9M | +$192M | JNJ, ALXN, BMY, MRK, AZN | 13F-HR | 8/14/2019, 06:02 AM |
| Q1 2019 | 0 | New Holdings | 6/20/2019, 07:37 AM | |||||
| Q1 2019 | 102 | $1.09B | +$373M | -$136M | +$237M | XBI, BMY, JNJ, FOLD, ALXN | 13F-HR | 5/15/2019, 06:23 AM |
| Q4 2018 | 88 | $747M | +$301M | -$83.3M | +$217M | XBI, MYL, MRK, BMY, CELG | 13F-HR | 2/14/2019, 05:42 AM |
| Q3 2018 | 111 | $869M | +$397M | -$45.3M | +$351M | XBI, MRK, MYL, JNJ, GSKXXXX | 13F-HR | 11/14/2018, 11:39 AM |
| Q2 2018 | 106 | $715M | +$326M | -$103M | +$224M | MRK, MYL, GSKXXXX, GILD, SHPG | 13F-HR | 8/13/2018, 08:30 AM |
| Q1 2018 | 104 | $646M | +$195M | -$168M | +$27.3M | XBI, MRK, SHPG, CELG, FOLD | 13F-HR | 5/10/2018, 08:44 AM |
| Q4 2017 | 132 | $846M | +$305M | -$66.1M | +$239M | XBI, IBB, CELG, MYL, MRK | 13F-HR | 2/12/2018, 01:44 PM |
| Q3 2017 | 128 | $694M | +$288M | -$34.9M | +$253M | XBI, CELG, BIIB, MRK, GILD | Restatement | 11/27/2017, 09:57 AM |
| Q2 2017 | 126 | $577M | +$209M | -$89.1M | +$120M | CELG, BIIB, MRK, GSKXXXX, GILD | 13F-HR | 8/9/2017, 10:08 AM |
| Q1 2017 | 108 | $490M | +$197M | -$5.98B | -$5.78B | CELG, BIIB, NVS, MRK, SRPT | 13F-HR | 5/11/2017, 06:08 AM |
| Q4 2016 | 103 | $391M | +$115M | -$111M | +$4.01M | MRK, CELG, TEVA, ALXN, CLCD | 13F-HR | 2/13/2017, 07:44 AM |
| Q3 2016 | 106 | $612M | +$316M | -$92.6M | +$223M | MRK, TEVA, SRPT, AGN, LLY | 13F-HR | 11/14/2016, 06:46 AM |
| Q2 2016 | 89 | $357M | +$149M | -$99.5M | +$49.7M | TEVA, AGN, GILD, LLY, CELG | 13F-HR | 8/10/2016, 10:17 AM |
| Q1 2016 | 88 | $445M | +$182M | -$33.9M | +$148M | PFE, TEVA, BIIB, AGN, GILD | 13F-HR | 5/16/2016, 06:17 AM |
| Q4 2015 | 116 | $639M | +$266M | -$107M | +$159M | TEVA, PFE, BIIB, AGN, ABBV | 13F-HR | 2/11/2016, 08:46 AM |
| Q3 2015 | 122 | $713M | +$311M | -$96.5M | +$215M | AGN, TEVA, BIIB, PFE, ABBV | 13F-HR | 11/16/2015, 05:05 AM |
| Q2 2015 | 122 | $981M | +$387M | -$89.3M | +$297M | AGN, GILD, PFE, ABBV, BIIB | 13F-HR | 8/6/2015, 01:19 PM |
| Q1 2015 | 142 | $932M | +$557M | -$3.12B | -$2.56B | B108PS, PFE, GILD, TEVA, ABBV | 13F-HR | 5/11/2015, 06:43 AM |
| Q4 2014 | 119 | $548M | +$184M | -$123M | +$61.4M | NVS, B108PS, PFE, TEVA, SLXP | 13F-HR | 2/12/2015, 11:42 AM |
| Q3 2014 | 122 | $751M | +$462M | -$51.8M | +$410M | NVS, PFE, TEVA, B108PS, MRK | Restatement | 11/20/2014, 06:33 AM |
| Q2 2014 | 96 | $379M | +$148M | -$70.1M | +$78.2M | NVS, MRK, TEVA, JNJ, PFE | Restatement | 8/20/2014, 06:03 AM |
| Q1 2014 | 105 | $395M | +$199M | -$135M | +$64.2M | NVS, GSKXXXX, MRK, PFE, JNJ | 13F-HR | 5/14/2014, 12:02 PM |
| Q4 2013 | 95 | $357M | GSKXXXX, PFE, XLF, MRK, SHPG | 13F-HR | 2/13/2014, 01:03 PM |